Who won: Next Generation Sequencing Testing (NGS)

About this contract

NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.

Who won contracts like this

• ✓Answer against the marking scheme, not the question text — NHS Blood and Transplant scores each response, so map your evidence to the published criteria and weightings.
• ✓Lead with evidenced capability and social value — for public sector work these usually outweigh price.
• ✓Show recent, comparable delivery: name similar public sector contracts you've delivered for public bodies, with measurable outcomes.
• ✓This one's been awarded — but NHS Blood and Transplant retenders on a cycle. Get matched the day the next one lands and start your draft early.

BidWriter drafts your responses from your company profile, scores them against the marking scheme, and tracks your whole pipeline. Free to start — no card needed.

Related resources